Catalyst Wire Dossier Catalyst Wire Dossier

Bimosiamose

bimosiamose · Revotar Biopharmaceuticals AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bimosiamose, covering 2010-01-06 to 2011-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing